Ticker: DVA

DaVita

Healthcare Healthcare Medical - Care Facilities

Price 181.66

Reco Buy Potential 65 Risk 40 Updated 2026-09-10

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell

Description

Company and Business Model

DaVita Inc. operates in the healthcare sector, primarily providing kidney care and dialysis services. The company offers a range of services including in-center hemodialysis, home dialysis, and related laboratory services. Its major business segments include dialysis services and ancillary services, with the majority of revenue generated from patient services in its dialysis centers. DaVita serves a diverse patient population across the United States and has a growing presence in international markets.

Investment Profile

The investment profile of DaVita is more aligned with growth investors, given its focus on expanding services and improving patient care. The company has shown potential for revenue growth despite recent fluctuations. It may appeal to investors looking for a balanced approach, considering its operational stability and market position.

Category: Healthcare Sector: Healthcare Industry: Medical - Care Facilities Investment style: Growth Horizon: Medium-term Company type: Blue Chip Company type: Market Leader

Fundamental metrics (experimental) Updated: 2026-09-07

EPS (TTM) — earnings per share for the last 12 months, $: 11.63
Revenue QoQ — quarter-over-quarter revenue growth: 4.1%
EPS surprise: 3.6%
20d volatility: 1.2%

AI recommendation changes

Date	Before	After	Reason
2026-09-08	Hold	Buy	Solid fundamentals, but mixed momentum signals present risk.
2026-08-29	Sell	Hold	Mixed momentum; fundamentals show promise but uncertainty remains.
2026-08-06	Hold	Sell	Weak fundamentals and negative momentum raise significant concerns.
2026-08-04	Buy	Hold	Weak revenue growth raises concerns despite strong past performance.
2026-07-11	Hold	Buy	Strong momentum and EPS surprise indicate growth potential.
2026-07-09	Buy	Hold	Weak revenue growth raises concerns despite positive EPS surprise.
2026-06-10	Hold	Buy	Strong momentum and positive EPS surprise support growth outlook.
2026-06-01	Buy	Hold	Strong momentum but recent revenue decline raises concerns.
2026-05-16	Hold	Buy	Strong momentum and positive EPS surprise support bullish outlook.
2026-05-08	—	Hold	Strong momentum and positive EPS surprise support growth outlook.
2026-05-07	Buy	Hold	Компания DaVita демонстрирует сильный рост цен акций за последние месяцы, что указывает на позитивные ожидания инвесторов. Несмотря на снижение выручки в квартальном выражении, высокий EPS и значительная положительная сю
2026-02-10	Hold	Buy	Компания DaVita демонстрирует сильный рост за последние 5 и 20 дней, что указывает на положительную динамику. Несмотря на отсутствие данных по EPS и дивидендам, текущая цена и рост на фоне общего рынка делают её привлека
2026-02-02	Sell	Hold	Компания DaVita демонстрирует смешанные результаты на рынке с недавним ростом, но общая тенденция показывает снижение за последние месяцы. Рекомендуется удерживать акции до получения более ясных сигналов о восстановлении
2026-01-24	Hold	Sell	Компания DaVita демонстрирует значительное снижение цен на акции за последние месяцы, что указывает на возможные проблемы в бизнесе. Отсутствие данных о прибыли и дивидендах также повышает риск инвестирования в данную ко
2026-01-22	Sell	Hold	Компания DaVita демонстрирует негативную динамику на длительном горизонте, однако недавний рост на 2.28% может свидетельствовать о краткосрочной коррекции. Рекомендуется удерживать акции до получения более ясных сигналов

Analyst forecasts

Date	Analyst	Action	Target	Price Then
2026-08-07	Truist Financial	Target Lowered	250 → 215	179.925
2026-08-07	Oppenheimer	Update	— → 220	180.67
2026-08-07	Raymond James	Update	— → 220	180.67
2026-08-05	Deutsche Bank	Target Raised	220 → 265	185.525
2026-08-05	Barclays	Target Raised	218 → 224	227.99
2026-07-14	Truist Financial	Target Raised	205 → 250	235.58
2026-07-10	UBS	Target Raised	235 → 270	229.48
2026-07-08	Barclays	Target Raised	194 → 218	234.31
2026-05-08	Truist Financial	Target Raised	158 → 205	194.385
2026-05-07	Barclays	Target Raised	158 → 194	193.88
2026-05-06	Deutsche Bank	Rating Upgraded	— → 220	157.04
2026-02-05	Truist Financial	Target Raised	128 → 158	144.415
2026-02-04	UBS	Target Raised	186 → 190	134.73
2026-02-03	Barclays	Target Raised	143 → 158	111.19
2025-10-30	Barclays	Target Lowered	149 → 143	126.56
2025-10-14	Truist Financial	Target Lowered	148 → 140	123.36
2025-10-09	Barclays	Target Lowered	160 → 149	127.89

News Page 1 of 1

Berkshire Hathaway’s CEO Greg Abel Implements Significant Cash Spending Strategy, Reducing Cash Reserves by 8%

08/09/2026, 05:31 AM investing announcement finance DaVita Alphabet

Berkshire Hathaway's new CEO, Greg Abel, significantly reduced the company's cash reserves by investing in share buybacks and equities, marking a strategic shift that could enhance shareholder confidence and reflect a more aggressive capital allocation approach.

Stocks Making Significant Moves Premarket: SpaceX, AMD, Eli Lilly, and Disney Report Mixed Results

08/05/2026, 05:37 AM business review Pixar Animation Studios Advanced Micro Devices SpaceX DaVita Wynn Resorts Arista Networks CVS Health Pinterest Eli Lilly

Premarket trading saw significant movements among several major companies, with SpaceX experiencing a notable decline following its quarterly report, while Eli Lilly and Arista Networks reported strong earnings that boosted their stock prices. These fluctuations reflect varying investor sentiments based on earnings performance and future guidance.

Stocks Post-Market: SpaceX Falls 7% Despite Revenue Beat; Arista Networks Rises 11% on Strong Earnings

08/04/2026, 02:39 PM business review Booking Holdings Inc. Advanced Micro Devices SpaceX DaVita Wynn Resorts Kratos Defense & Security Solutions Arista Networks Teradata Pinterest

Several companies experienced significant stock movements after their earnings reports, with notable gains for Arista Networks and Wynn Resorts, while SpaceX and AMD faced declines despite reporting revenues above expectations.